Regulatory Insights
-
Unlock Oncology Success With A Comprehensive Commercialization Guide
8/22/2025
Navigate the complex process of bringing an oncology therapy to market, from regulatory planning to patient access and supply chain logistics, with this comprehensive handbook for developers.
-
Audit Trails And Transparency: Changes In Clinical Data
8/18/2025
Audit trails are not only a regulatory necessity but a strategic tool to ensure data reliability and accelerate high-quality clinical research outcomes.
-
2025 Global Report For In-Vivo CAR Cell Therapy
8/14/2025
Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases.
-
LBPs: Unique Quality, Manufacturing, And Nonclinical Considerations
8/14/2025
Live biotherapeutic products (LBPs) are emerging as a dynamic area of drug development, and their development demands tailored strategies that address both manufacturing and nonclinical complexities.
-
Understanding Immunogenicity In AAV Gene Therapy
8/14/2025
As adeno-associated virus-based gene therapies progress toward clinical use, effectively managing immunogenicity risk is critical to patient selection, therapeutic durability, and regulatory success.
-
Gene Therapy Studies Rose While Financing Declined In Q2 2025
8/13/2025
There were three new approvals across the therapeutic landscape in the second quarter of 2025, but despite those positive signs, overall dealmaking was flat for the quarter.
-
Demanding More From AI Governance In Drug Safety
8/13/2025
Embedding AI governance into your an AI-enabled safety system from the start empowers trust and streamlines the path toward success; it is merely the evolution of good data and risk governance.
-
Navigating Global Health Policy In A Time Of Disruption
8/12/2025
The healthcare industries in the U.S. and EU are undergoing significant regulatory and legislative changes. Learn how to better position yourself to navigate this complex environment.
-
Thinking Ahead: How Integrated Development Plans Improve Product Success
8/12/2025
How can integrated development planning reduce development timelines and increase your chances of commercialization success? Industry experts reveal how this approach helps avoid common pitfalls.
-
How PIE Streamlines Biopharma And Payer Communication
8/12/2025
Navigating pre-approval information exchange (PIE) with healthcare decision-makers is essential for market success. Learn what information can be shared and the best strategies for communication.